-
Study aim
-
Comparison of pain and agitation and nausea and vomiting and time and dose of analgesic in rupivacaine plus dexamethasone and rupivacaine plus ketamine
-
Design
-
In this double-blind clinical trial study, 5 patients, aged 2 to 4 years, referred to Amir Kabir Hospital, Arak, were diagnosed with tonsillectomy and met inclusion criteria after obtaining informed consent. Patients under study were divided into two groups: dexamethasone and ketamine.
-
Settings and conduct
-
Given the double-blindness, only the primary investigator is aware of the groups and drugs used in this study, and patients and interns are responsible for collecting data from the groups and drugs used. This study was performed in Amirkabir hospital in Arak in 1398 in which all patients underwent tracheal anesthesia after entering the operating room. Then, the interventions are performed by the surgeon and their consequences are statistically analyzed.The extent of pain is determined by VAS ruler at 15, 30 and 2, 4, 8, 16, 24 hours, Agitation was measured by the Riker Sedation-Agitation scale at 15, 30, and 2, 4, 8, 16, and 24 minutes after surgery.
-
Participants/Inclusion and exclusion criteria
-
Children between the ages of 3 and 5 years are candidates for elective tonsillectomy in the absence of underlying disease and no history of motion sickness. If surgery lasts more than 2 hours and bleeding exceeds 10 cc / kg, the study will be excluded.
-
Intervention groups
-
In the first group, the surgeon delivered 2 cc of 0.5% ropivacaine solution plus dexamethasone 0.5 mg / kg (maximum 1 mg) with distilled water to CC 10 and in the second group 2 cc of ropivacaine solution 0.5% plus ketamine 0.5 mg / kg. With the help of distilled water, it reaches CC 10 and is injected into the peritonsillar fossa by the surgeon so that the injection is only in the sub mucus area. 5cm injection is given on each side.
-
Main outcome variables
-
Pain; Agitation